| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
UroGen Pharma Ltd (NASDAQ: URGN)
URGN Technical Analysis
5
| As on 9th Jun 2023 URGN STOCK Price closed @ 11.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.17 & Strong Buy for SHORT-TERM with Stoploss of 7.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
URGNSTOCK Price
| Open | 10.99 | Change | Price | % |
| High | 11.75 | 1 Day | 0.59 | 5.33 |
| Low | 10.78 | 1 Week | 1.75 | 17.68 |
| Close | 11.65 | 1 Month | -0.81 | -6.50 |
| Volume | 129612 | 1 Year | 2.53 | 27.74 |
| 52 Week High 14.29 | 52 Week Low 5.12 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| URGN Daily Charts |
URGN Intraday Charts |
Whats New @ Bazaartrend |
URGN Free Analysis |
|
|
URGN Important Levels Intraday
| RESISTANCE | 13.52 |
| RESISTANCE | 12.92 |
| RESISTANCE | 12.55 |
| RESISTANCE | 12.18 |
| SUPPORT | 11.12 |
| SUPPORT | 10.75 |
| SUPPORT | 10.38 |
| SUPPORT | 9.78 |
URGN Forecast May 2024
| 4th UP Forecast | 16.87 |
| 3rd UP Forecast | 15.2 |
| 2nd UP Forecast | 14.16 |
| 1st UP Forecast | 13.13 |
| 1st DOWN Forecast | 10.17 |
| 2nd DOWN Forecast | 9.14 |
| 3rd DOWN Forecast | 8.1 |
| 4th DOWN Forecast | 6.43 |
URGN Weekly Forecast
| 4th UP Forecast | 14.06 |
| 3rd UP Forecast | 13.29 |
| 2nd UP Forecast | 12.81 |
| 1st UP Forecast | 12.33 |
| 1st DOWN Forecast | 10.97 |
| 2nd DOWN Forecast | 10.49 |
| 3rd DOWN Forecast | 10.01 |
| 4th DOWN Forecast | 9.24 |
URGN Forecast2024
| 4th UP Forecast | 33.35 |
| 3rd UP Forecast | 26.39 |
| 2nd UP Forecast | 22.09 |
| 1st UP Forecast | 17.79 |
| 1st DOWN Forecast | 5.51 |
| 2nd DOWN Forecast | 1.21 |
| 3rd DOWN Forecast | -3.09 |
| 4th DOWN Forecast | -10.05 |
UroGen Pharma Ltd ( NASDAQ USA Symbol : URGN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
URGN Business Profile
UroGen Pharma Ltd., a biopharmaceutical company, engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-302 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. It also has a strategic research agreement with the Johns Hopkins University to explore the potential of checkpoint inhibitors combined with RTGel in glioblastoma multiform. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey. Address: 400 Alexander Park, Princeton, NJ, United States, 08540
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service